miércoles, 21 de agosto de 2013

MR analysis shows brain tumor response to anti-antiogenesis drugs - National Cancer Institute

MR analysis shows brain tumor response to anti-antiogenesis drugs - National Cancer Institute
National Cancer Institute at the National Institutes of Health
NCI Cancer Center News

New MR analysis technique reveals brain tumor response to anti-angiogenesis therapy

A new way of analyzing data acquired in MR imaging appears to be able to identify whether or not tumors are responding to anti-angiogenesis therapy, information that can help physicians determine the most appropriate treatments and discontinue ones that are ineffective. In their report receiving online publication in Nature Medicine, investigators from the Martinos Center for Biomedical Imaging at Massachusetts General Hospital (a component of the Dana-Farber Cancer Institute), describe how their technique, called vessel architectural imaging (VAI), was able to identify changes in brain tumor blood vessels within days of the initiation of anti-angiogenesis therapy.
Click here to read full press release Exit Disclaimer.
###
NCI comprehensive cancer centers logoAmong the research institutions NCI funds across the United States, it currently designates 67 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.

No hay comentarios:

Publicar un comentario